招商中证生物科技主题ETF(159849)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
5,642,373.45 |
-17,631,910.55 |
-22,447,831.18 |
-10,015,706.06 |
| 利息合计 |
2,211.61 |
5,369.69 |
2,102.38 |
6,718.68 |
| 其中：存款利息收入 |
2,211.61 |
5,369.69 |
2,102.38 |
6,718.68 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-8,825,079.52 |
-29,136,385.74 |
-7,087,415.69 |
-8,122,355.09 |
| 其中：股票投资收益 |
-9,389,682.33 |
-30,330,851.27 |
-7,817,770.78 |
-9,335,123.87 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
564,602.81 |
1,194,465.53 |
730,355.09 |
1,212,768.78 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
14,353,464.19 |
11,474,902.71 |
-15,380,572.14 |
-1,891,025.91 |
| 其他收入 |
111,777.17 |
24,202.79 |
18,054.27 |
-9,043.74 |
| 费用 |
272,349.36 |
584,664.69 |
318,355.91 |
728,988.62 |
| 管理人报酬 |
184,099.84 |
387,220.59 |
199,831.09 |
482,490.55 |
| 基金托管费 |
36,819.96 |
77,444.10 |
39,966.20 |
96,498.07 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
51,429.56 |
120,000.00 |
78,558.62 |
150,000.00 |
| 利润总额 |
5,370,024.09 |
-18,216,575.24 |
-22,766,187.09 |
-10,744,694.68 |
微信公众号
证券之星APP
基本资料
